Skip to content

Cervicitis by Iontophoresis

Effectiveness of Iontophoresis in Managing Uterine Cervicitis

Status
UNKNOWN
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05675293
Enrollment
40
Registered
2023-01-09
Start date
2023-01-15
Completion date
2023-02-28
Last updated
2023-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CERVICITIS

Brief summary

The purpose of the study is to: Investigate effect of iontophoresis on managing uterine cervicitis.

Interventions

The process of increasing the penetration of drugs into the skin by application of an electric current

Oral Antibiotic

Sponsors

October 6 University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

1. All patients have vaginal discharge. 2. All patients have irregular vaginal bleeding, especially after sexual intercourse. 3. All patients have dyspareunia. 4. All patients have Lower abdominal pain. 5. Group A: 20 women will receive oral medication (antibiotic zesrosin) and hot water with antiseptic. 6. Group B: 20 women will receive medication by iontophoresis (antibiotic ceftriaxone) and hot water with antiseptic.

Exclusion criteria

1. Patients with a history of hypersensitivity or adverse reactions associated with the delivered drug in (ceftriaxone). 2. Patients with prior medical histories of cardiac arrhythmias or hypercoagulability should not receive the procedure near cardiac pacemakers and superficial blood vessels. 3. In the vicinity of embedded wires, stapes, orthopedic implants, and areas of skin with lesions and impaired sensation. 4. It either should not be used or used with extreme caution during pregnancy.

Design outcomes

Primary

MeasureTime frameDescription
Difference in change in Urine Analysis and Cervical swab results in both groups7 Days difference between pre and post testsPresence of Pus Cells in Urine Analysis and a Positive Cervical swab results

Contacts

Primary ContactMARIAM HELMY, DEMONSTRATOR
MARIAMHELMYMHR@GMAIL.COM01129985772

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026